[Use of complement-inhibiting substance in passive-anaphylactic hemolysin shock].
D003165:Complement System Proteins; D006460:Hemolysin Proteins; D006801:Humans; D006967:Hypersensitivity; D007154:Immune System Diseases
D006460:Hemolysin Proteins; D003165:Complement System Proteins
ALLERGY/experimental; COMPLEMENT
Uber die Anwendung komplementhemmender Substanzen beim passivanaphylaktischen Hämolysinschock.